Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Non-Small-Cell Lung
×
canakinumab
×
Clear all
Filters
3
NCT03447769
2024-10-09
Canopy-A
Novartis
Phase 3
Terminated
1,382 enrolled
23 charts
NCT03626545
2023-08-21
CANOPY-2
Novartis
Phase 3
Terminated
245 enrolled
29 charts